Security key
137404109
Candel Therapeutics, Inc. - Common Stock, $0.01 par value (CADL)
CUSIP: 137404109
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / Common Stock, $0.01 par value
- Shares outstanding
- 72,977,477
- Total 13F shares
- 6,080,809
- Share change
- -265,373
- Total reported value
- $19,096,287
- Price per share
- $3.14
- Number of holders
- 22
- Value change
- -$834,398
- Number of buys
- 8
- Number of sells
- 5
Report period
Q3 2022
Institutions
22
Top holders
10
CADL full security history
Newer quarter: Q4 2022
Previous quarter: Q2 2022
Candel Therapeutics, Inc. SEC filings
Candel Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 137404109
Recent filing periods:
Top shareholders of CADL - Candel Therapeutics, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Northpond Ventures, LLC |
13F
|
Company |
2.7%
|
1,935,215
|
$6,270,000 | — | 30 Jun 2022 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.5%
|
1,125,000
|
$3,645,000 | — | 30 Jun 2022 | |
| FMR LLC |
13F
|
Company |
1.2%
|
899,399
|
$2,914,000 | — | 30 Jun 2022 | |
| Sands Capital Alternatives, LLC |
13F
|
Company |
1.1%
|
811,737
|
$2,630,000 | — | 30 Jun 2022 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1%
|
743,082
|
$2,408,000 | — | 30 Jun 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.56%
|
405,461
|
$1,313,000 | — | 30 Jun 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.18%
|
132,700
|
$430,000 | — | 30 Jun 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.18%
|
129,377
|
$420,000 | — | 30 Jun 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
75,217
|
$243,000 | — | 30 Jun 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.04%
|
27,600
|
$89,000 | — | 30 Jun 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.02%
|
14,483
|
$47,000 | — | 30 Jun 2022 | |
| Kestra Advisory Services, LLC |
13F
|
Company |
0.02%
|
12,500
|
$41,000 | — | 30 Jun 2022 | |
| Empirical Asset Management, LLC |
13F
|
Company |
0.02%
|
12,000
|
$39,000 | — | 30 Jun 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.01%
|
10,037
|
$33,000 | — | 30 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
4,621
|
$15,000 | — | 30 Jun 2022 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
3,807
|
$12,000 | — | 30 Jun 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
1,247
|
$4,000 | — | 30 Jun 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,219
|
$4,000 | — | 30 Jun 2022 | |
| Point72 Hong Kong Ltd |
13F
|
Company |
0%
|
640
|
$2,000 | — | 30 Jun 2022 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
430
|
$1,000 | — | 30 Jun 2022 | |
| Quent Capital, LLC |
13F
|
Company |
0%
|
182
|
$1,000 | — | 30 Jun 2022 | |
| Laura K. Aguilar |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
3,046,940
|
$2,742,246 | — | 06 May 2022 | |
| Udi Meirav |
3/4/5
|
Director |
—
class O/S missing
|
48,822
|
$43,940 | — | 26 Jul 2021 | |
| SMITH ALAN E |
3/4/5
|
Director |
—
class O/S missing
|
32,548
|
$29,293 | — | 26 Jul 2021 | |
| Nathan Caffo |
3/4/5
|
Chief Business Officer |
—
class O/S missing
|
6,000
|
$5,400 | — | 29 Jul 2021 | |
| John J. Canepa |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
110,000
|
— | — | 28 Feb 2022 | |
| Susan B. Stewart |
3/4/5
|
Chief Regulatory Officer |
—
class O/S missing
|
20,000
|
— | — | 11 Apr 2022 |
Institutional Holders of Candel Therapeutics, Inc. - Common Stock, $0.01 par value (CADL) as of Q3 2022
As of 30 Sep 2022,
Candel Therapeutics, Inc. - Common Stock, $0.01 par value (CADL) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,080,809 shares.
The largest 10 holders included
Northpond Ventures, LLC, FRANKLIN RESOURCES INC, FMR LLC, Sands Capital Ventures, LLC, VANGUARD GROUP INC, Point72 Asset Management, L.P., BRIDGEWAY CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., and STATE STREET CORP.
This page lists
22
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
21
Q3 2022 holders
22
Holder diff
1
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.